| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 1 263-268, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JF Urban Jr, R Fayer, SJ Chen, WC Gause, MK Gately and FD Finkelman
Parasite Immunobiology Laboratory, United States Department of Agriculture, Beltsville, MD 20705, USA.
The protozoan parasite Cryptosporidium parvum (Cp) causes diarrhea that can be acutely severe in immunocompetent persons and can become chronic and life-threatening in immunocompromised individuals. Because studies in mice have implicated IFN-gamma in protection against this parasite, and IL-12 can induce IFN-gamma production, we examined the ability of IL-12 to prevent or cure Cp infection in neonatal BALB/c and SCID mice. Treatment of both immunocompetent and immunodeficient mice with IL-12 before experimental inoculation with Cp oocysts prevented or greatly reduced the severity of infection. Intestinal epithelial cell invasion and/or early intracellular development of Cp was inhibited by exogenous IL-12. The protective effect of IL-12 was completely blocked by anti- IFN-gamma mAb. Established infections were associated with elevated IFN- gamma gene expression and were not ameliorated by IL-12 treatment, even though such treatment further enhanced IFN-gamma gene expression. The severity of Cp infection was, however, exacerbated by treatment with anti-IL-12 Ab. These observations provide the first evidence that treatment with exogenous IL-12 can prevent Cp infection through an IFN- gamma-dependent, specific immune system-independent mechanism, and that endogenous IL-12 production has a role in limiting Cp infection.
This article has been cited by other articles:
|
|
 |
|
  K. A. Rogers, A. B. Rogers, B. A. Leav, A. Sanchez, E. Vannier, S. Uematsu, S. Akira, D. Golenbock, and H. D. Ward MyD88-Dependent Pathways Mediate Resistance to Cryptosporidium parvum Infection in Mice Infect. Immun., January 1, 2006; 74(1): 549 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Zaalouk, M. Bajaj-Elliott, J. T. George, and V. McDonald Differential Regulation of {beta}-Defensin Gene Expression during Cryptosporidium parvum Infection Infect. Immun., May 1, 2004; 72(5): 2772 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-S. Lean, S. A. C. McDonald, M. Bajaj-Elliott, R. C. G. Pollok, M. J. G. Farthing, and V. McDonald Interleukin-4 and Transforming Growth Factor {beta} Have Opposing Regulatory Effects on Gamma Interferon-Mediated Inhibition of Cryptosporidium parvum Reproduction Infect. Immun., August 1, 2003; 71(8): 4580 - 4585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Hunter and G. Nichols Epidemiology and Clinical Features of Cryptosporidium Infection in Immunocompromised Patients Clin. Microbiol. Rev., January 1, 2002; 15(1): 145 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Hayward, M. Cosyns, M. Jones, and E. M. Ponnuraj Marrow-Derived CD40-Positive Cells Are Required for Mice To Clear Cryptosporidium parvum Infection Infect. Immun., March 1, 2001; 69(3): 1630 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lacroix, R. Mancassola, M. Naciri, and F. Laurent Cryptosporidium parvum-Specific Mucosal Immune Response in C57BL/6 Neonatal and Gamma Interferon-Deficient Mice: Role of Tumor Necrosis Factor Alpha in Protection Infect. Immun., March 1, 2001; 69(3): 1635 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. MOSIER and R. D. OBERST Cryptosporidiosis: A Global Challenge Ann. N.Y. Acad. Sci., December 1, 2000; 916(1): 102 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Waters, B. Frydman, L. J. Marton, A. Valasinas, V. K. Reddy, J. A. Harp, M. J. Wannemuehler, and N. Yarlett [1N,12N]Bis(Ethyl)-cis-6,7-Dehydrospermine: a New Drug for Treatment and Prevention of Cryptosporidium parvum Infection of Mice Deficient in T-Cell Receptor Alpha Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2891 - 2894. [Abstract] [Full Text]
|
|
|
|
|
|
K. Lukin, M. Cosyns, T. Mitchell, M. Saffry, and A. Hayward Eradication of Cryptosporidium parvum Infection by Mice with Ovalbumin-Specific T Cells Infect. Immun., May 1, 2000; 68(5): 2663 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Arulanandam, J. N. Mittler, W. T. Lee, M. O'Toole, and D. W. Metzger Neonatal Administration of IL-12 Enhances the Protective Efficacy of Antiviral Vaccines J. Immunol., April 1, 2000; 164(7): 3698 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Urban Jr., L. Schopf, S. C. Morris, T. Orekhova, K. B. Madden, C. J. Betts, H. R. Gamble, C. Byrd, D. Donaldson, K. Else, et al. Stat6 Signaling Promotes Protective Immunity Against Trichinella spiralis Through a Mast Cell- and T Cell-Dependent Mechanism J. Immunol., February 15, 2000; 164(4): 2046 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Leitch and Q. He Reactive Nitrogen and Oxygen Species Ameliorate Experimental Cryptosporidiosis in the Neonatal BALB/c Mouse Model Infect. Immun., November 1, 1999; 67(11): 5885 - 5891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Clark New Insights into Human Cryptosporidiosis Clin. Microbiol. Rev., October 1, 1999; 12(4): 554 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Muraille, B. Pajak, J. Urbain, M. Moser, and O. Leo Role and regulation of IL-12 in the in vivo response to staphylococcal enterotoxin B Int. Immunol., September 1, 1999; 11(9): 1403 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Genovese, G. Mancuso, M. Cuzzola, C. Biondo, C. Beninati, D. Delfino, and G. Teti Role of IL-10 in a Neonatal Mouse Listeriosis Model J. Immunol., September 1, 1999; 163(5): 2777 - 2782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Adjei, J. T. Jones, M. W. Riggs, and F. J. Enriquez Evidence of Thymus-Independent Local and Systemic Antibody Responses to Cryptosporidium parvum Infection in Nude Mice Infect. Immun., August 1, 1999; 67(8): 3947 - 3951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sam and M. M. Stevenson In Vivo IL-12 Production and IL-12 Receptors {beta}1 and {beta}2 mRNA Expression in the Spleen Are Differentially Up-Regulated in Resistant B6 and Susceptible A/J Mice During Early Blood-Stage Plasmodium chabaudi AS Malaria J. Immunol., February 1, 1999; 162(3): 1582 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Silva, T. F. Pais, and R. Appelberg Evaluation of IL-12 in Immunotherapy and Vaccine Design in Experimental Mycobacterium avium Infections J. Immunol., November 15, 1998; 161(10): 5578 - 5585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Aguirre, L. E. Perryman, W. C. Davis, and T. C. McGuire IL-4 Protects Adult C57BL/6 Mice from Prolonged Cryptosporidium parvum Infection: Analysis of CD4+{alpha}{beta}+IFN-{gamma}+ and CD4+{alpha}{beta}+IL-4+ Lymphocytes in Gut-Associated Lymphoid Tissue During Resolution of Infection J. Immunol., August 15, 1998; 161(4): 1891 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cosyns, S. Tsirkin, M. Jones, R. Flavell, H. Kikutani, and A. R. Hayward Requirement for CD40-CD40 Ligand Interaction for Elimination of Cryptosporidium parvum from Mice Infect. Immun., February 1, 1998; 66(2): 603 - 607. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
